Sharing the summary report from our #CPHIA2025 session in #Durban South Africa titled: Harnessing the African Diaspora and Private Sector for Health Innovation. It's a 5 minute watch, a well-invested time... https://t.co/tp4ma07J1E
#AfricaCDC#AHCF#AfricanHealthCatalystForum
#Africa’s #PublicHealth story needs better telling — and we’re looking for someone to help tell it.
EpiSolutions is hiring a #Communications#Intern. 6 months, remote, real work, unpaid.
Network. Mentorship. Internet costs covered.
Rolling applications https://t.co/mRvb3qRukU
Check out my latest article: From “Your Turn to Suffer” to Shared Abundance: One More Reason to Build Self-Reliant Health Systems in Africa https://t.co/rLtygZo68B via @LinkedIn
Check out my latest article: From “Your Turn to Suffer” to Shared Abundance: One More Reason to Build Self-Reliant Health Systems in Africa https://t.co/rLtygZnyj3 via @LinkedIn
Preventing Disruptions in HIV Service Delivery to Key Populations During Project Transition From an International to a Local Implementing Partner: A Case Study From Zambia https://t.co/pSS2mrKMeK
Harnessing the African Diaspora & Private Sector for Health Innovation & Financing.
The African diaspora & private sector together represent Africa’s most underutilized assets for health financing & innovation. #CPHIA2025 side event, see details here -
https://t.co/2qeVL8LIln
⚠️ 1.3 million people acquired HIV in 2024 alone, including thousands of adolescent girls and young women.
Today, in a landmark move towards HIV prevention, WHO recommends twice-yearly injectable lenacapavir as pre-exposure prophylaxis (PrEP) to protect people at risk of HIV⚠️ 1.3 million people acquired HIV in 2024 alone, including thousands of adolescent girls and young women.
Today, in a landmark move towards HIV prevention, WHO recommends twice-yearly injectable lenacapavir as pre-exposure prophylaxis (PrEP) to protect people at risk of HIV⚠️ 1.3 million people acquired HIV in 2024 alone, including thousands of adolescent girls and young women.
Today, in a landmark move towards HIV prevention, WHO recommends twice-yearly injectable lenacapavir as pre-exposure prophylaxis (PrEP) to protect people at risk of HIV⚠️ 1.3 million people acquired HIV in 2024 alone, including thousands of adolescent girls and young women.
Today, in a landmark move towards HIV prevention, WHO recommends twice-yearly injectable lenacapavir as pre-exposure prophylaxis (PrEP) to protect people at risk of HIV.
How may we get "𝗠𝗼𝗿𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 for the 𝗠𝗼𝗻𝗲𝘆?
You're invited to contribute your valuable insights. There's a 30-minute open mic session dedicated to hearing voices not on the panel.
You can register now to participate - https://t.co/wH88CdF9r9
How may we get "𝗠𝗼𝗿𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 for the 𝗠𝗼𝗻𝗲𝘆?
You're invited to contribute your valuable insights. There's a 30-minute open mic session dedicated to hearing voices not on the panel.
You can register now to participate - https://t.co/wH88CdF9r9
Contribute to action for the future of Africa's health NOW!
Join us for "Africa's Roadmap to Self-Reliant Healthcare" Roundtable Series, starting May 28th at 3 PM GMT on Zoom (registration required).
Register now: https://t.co/4N143CpGZR
#Health#PublicHealth#Africa#ActNow